{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:21:45Z","timestamp":1768832505808,"version":"3.49.0"},"reference-count":51,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,12,7]],"date-time":"2007-12-07T00:00:00Z","timestamp":1196985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Emerging evidence implicates metabotropic glutamate receptor (mGluR) function in the neurobiological effects of ethanol. The recent development of subtype specific mGluR antagonists has made it possible to examine the roles of specific mGluRs in biochemical and behavioral responses to ethanol. The purpose of the present study was to determine if mGluRs modulate the acute sedative\u2010hypnotic properties of ethanol in mice.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> C57BL\/6J mice were tested for locomotor activity (sedation) and duration of loss of the righting reflex (hypnosis) following acute systemic administration of ethanol alone or in combination with the mGluR5\u2010selective antagonist, 2\u2010methyl\u20106\u2010(phenylethynyl)pyridine (MPEP), the mGluR1\u2010selective antagonist, 7\u2010(hydroxyimino)cyclopropa[b]chromen\u20101a\u2010carboxylate ethyl ester (CPCCOEt), or the mGluR2\/3\u2010selective antagonist (2S)\u20102\u2010Amino\u20102\u2010[(1S,2S)\u20102\u2010carboxycycloprop\u20101\u2010yl]\u20103\u2010(xanth\u20109\u2010yl) propanoic acid (LY341495)).<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> MPEP (10 and 30\u2003mg\/kg) significantly enhanced both the sedative and hypnotic effects of ethanol, while LY341495 (10 and 30\u2003mg\/kg) significantly reduced the sedative\u2010hypnotic effects of ethanol. CPCCOEt had no effect at any concentration tested. Further loss of righting reflex experiments revealed that LY341495 (30\u2003mg\/kg) significantly reduced hypnosis induced by the gamma\u2010aminobutyric acid type A (GABAA) positive modulators, pentobarbital (50\u2003mg\/kg) and midazolam (60\u2003mg\/kg), and the <jats:italic>N<\/jats:italic>\u2010methyl\u2010<jats:sc>d<\/jats:sc>\u2010aspartate (NMDA) receptor antagonist, ketamine (150\u2003mg\/kg), while MPEP (30\u2003mg\/kg) only significantly enhanced the hypnotic properties of ketamine (150\u2003mg\/kg).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> These findings suggest that specific subtypes of the metabotropic glutamate receptor differentially modulate the sedative\u2010hypnotic properties of ethanol through separate mechanisms of action, potentially involving GABA<jats:sub>A<\/jats:sub> and NMDA receptors.<\/jats:p>","DOI":"10.1111\/j.1530-0277.2007.00554.x","type":"journal-article","created":{"date-parts":[[2008,9,17]],"date-time":"2008-09-17T12:35:42Z","timestamp":1221654942000},"page":"67-76","source":"Crossref","is-referenced-by-count":36,"title":["Differential Modulation of Ethanol\u2010Induced Sedation and Hypnosis by Metabotropic Glutamate Receptor Antagonists in C57BL\/6J Mice"],"prefix":"10.1111","volume":"32","author":[{"given":"Amanda C.","family":"Sharko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clyde W.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,12,7]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0092-6"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703904"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300381"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(96)00140-1"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-22-09679.2002"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300616"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.08.071"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000156116.40817.A2"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0750889.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(99)00242-7"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704315"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm025570j"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.090449"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0583-0"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00082-X"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(02)00179-9"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(97)00001-4"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-10-06879.1995"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)80442-0"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)00912-8"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.alc.0000183009.57805.a6"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.10261"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0217-y"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.2002.88.4.1766"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300417"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2005.09.058"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-2200-z"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(99)00066-0"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.04.003"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705159"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.53.1.148"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00044-2"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0953-816x.2001.01601.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1997.78.1.63"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2002.tb02550.x"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(03)01342-6"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703715"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(94)00129-G"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(01)00297-4"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199803000-00030"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-2175-9"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2003.052209"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000139825.35438.A4"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199609020-00010"},{"key":"e_1_2_6_46_1","first-page":"1267","article-title":"Anxiolytic\u2010like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2\u2010methyl\u20106\u2010(phenylethynyl)pyridine in rodents","volume":"295","author":"Spooren WP","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-2143-4"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(98)00055-4"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.05187.x"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300322"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2007.00423.x"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.1.162"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1530-0277.2007.00554.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1530-0277.2007.00554.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:14:39Z","timestamp":1697156079000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1530-0277.2007.00554.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1111\/j.1530-0277.2007.00554.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1530-0277.2007.00554.x","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,7]]}}}